Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sjögren’s syndrome via suppression of the CX3CL1/CX3CR1 axis
Open Access
- 21 October 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1465938
Abstract
Introduction: Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by the infiltration of immune cells into the salivary glands. The re-establishment of salivary glands (SGs) function in pSS remains a clinical challenge. Myeloid-derived growth factor (MYDGF) has anti-inflammatory, immunomodulatory, and tissue-functional restorative abilities. However, its potential to restore SGs function during pSS has not yet been investigated.Methods: Nonobese diabetic (NOD)/LtJ mice (pSS model) were intravenously administered with adeno-associated viruses carrying MYDGF at 11 weeks of age. Salivary flow rates were determined before and after treatment. Mice were killed 5 weeks after MYDGF treatment, and submandibular glands were collected for analyses of histological disease scores, inflammatory cell infiltration, PCR determination of genes, and Western blotting of functional proteins. Furthermore, mRNA sequencing and bioinformatics were used to predict the mechanism underlying the therapeutic effect of MYDGF.Results: Treatment of NOD/LtJ mice with MYDGF alleviated pSS, as indicated by increased salivary flow rate, reduced lymphocyte infiltration, attenuated glandular inflammation, and enhanced AQP5 and NKCC1 expression. The gene expression levels of cytokines and chemokines, including Ccl12, Ccl3, Il1r1, Ccr2, Cx3cr1, Il7, Mmp2, Mmp14, Il1b, and Il7, significantly decreased after treatment with MYDGF, as determined by RNA sequencing. Meanwhile, MYDGF inhibits infiltration of macrophages (Mϕ) in SGs, induces polarization of M2ϕ, and suppresses C-X3C motif ligand 1 (CX3CL1)/C-X3C motif receptor 1 (CX3CR1) axis.Conclusions: Our findings showed that MYDGF could revitalize the SGs function of pSS, inhibit infiltration of Mϕ, and promote M2ϕ polarization via suppression of the CX3CL1/CX3CR1 axis, which has implications for potential therapy for pSS.Keywords
This publication has 36 references indexed in Scilit:
- Myeloid-derived growth factor ameliorates dextran sodium sulfate-induced colitis by regulating macrophage polarizationJournal of Molecular Medicine, 2024
- Myeloid-derived growth factor and its effects on cardiovascular and metabolic diseasesCytokine & Growth Factor Reviews, 2023
- Involvement of aquaporin 5 in Sjögren’s syndromeAutoimmunity Reviews, 2023
- In Vivo Generation of SSA/Ro Antigen–Specific Regulatory T Cells Improves Experimental Sjögren's Syndrome in MiceArthritis & Rheumatology, 2022
- Myeloid-derived growth factor regulates high glucose-mediated apoptosis of gingival fibroblasts and induce AKT pathway activation and nuclear factor κB pathway inhibitionJournal of Dental Sciences, 2022
- A paracrine network regulates the cross-talk between human lung stem cells and the stromaNature Communications, 2014
- Critical Involvement of Macrophage Infiltration in the Development of Sjögren's Syndrome–Associated Dry EyeThe American Journal of Pathology, 2012
- Bone marrow-derived cells: A potential approach for the treatment of xerostomiaThe International Journal of Biochemistry & Cell Biology, 2011
- Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic miceThe International Journal of Biochemistry & Cell Biology, 2010
- T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of PathophysiologyClinical Reviews in Allergy & Immunology, 2007